The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors
Open accessAbstract
Inflammation in the central nervous system (CNS) is a complex process that involves a multitude of molecules and effectors, and it requires the transmigration of blood leukocytes across the blood-brain barrier (BBB) and the activation of resident immune cells. Cannabidiol (CBD), a non-psychotropic cannabinoid constituent of Cannabis sativa, has potent anti-inflammatory and immunosuppressive properties. Yet, how this compound modifies the deleterious effects of inflammation in TMEV-induced demyelinating disease (TMEV-IDD) remains unknown. Using this viral model of multiple sclerosis (MS), we demonstrate that CBD decreases the transmigration of blood leukocytes by downregulating the expression of vascular cell adhesion molecule-1 (VCAM-1), chemokines (CCL2 and CCL5) and the proinflammatory cytokine IL-1β, as well as by attenuating the activation of microglia. Moreover, CBD administration at the time of viral infection exerts long-lasting effects, ameliorating motor deficits in the chronic phase of the disease in conjunction with reduced microglial activation and pro-inflammatory cytokine production. Adenosine A2A receptors participate in some of the anti-inflammatory effects of CBD, as the A2A antagonist ZM241385 partially blocks the protective effects of CBD in the initial stages of inflammation. Together, our findings highlight the anti-inflammatory effects of CBD in this viral model of MS and demonstrate the significant therapeutic potential of this compound for the treatment of pathologies with an inflammatory component.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
El‐Remessy, A. B., Tang, Y., Zhu, G., Matragoon, S., Khalifa, Y., Liu, E. K., Liu, J.-Y., Hanson, E. M., Mian, S. I., Fatteh, N., et al. (2008) · PubMed · Cited by 70
RetractedMonocyte Chemoattractant Protein-1 (MCP-1): An Overview
Deshmane, S. L., Kremlev, S., Amini, S., & Sawaya, B. E. (2009) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2008.0027 · Cited by 3,889
Properties Of The Novel Proinflammatory Supergene Intercrine Cytokine Family
Oppenheim, J. (1991) · Annual Review of Immunology · doi:10.1146/annurev.immunol.9.1.617 · Cited by 1,877
Multiple Sclerosis: An Immune or Neurodegenerative Disorder?
Trapp, B. D., & Nave, K.-A. (2008) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.30.051606.094313 · Cited by 1,724
Bisogno, T., Hanuš, L., De Petrocellis, L., Tchilibon, S., Ponde, D. E., Brandi, I., Moriello, A. S., Davis, J. B., Mechoulam, R., & Di Marzo, V. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704327 · Cited by 1,311
Cannabidiol and (−)Δ 9 -tetrahydrocannabinol are neuroprotective antioxidants
Hampson, A. J., Grimaldi, M., Axelrod, J., & Wink, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8268 · Cited by 850
Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb
Izzo, A. A., Borrelli, F., Capasso, R., Di Marzo, V., & Mechoulam, R. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.07.006 · Cited by 820
Thomas, A., Baillie, G. L., Phillips, A. M., Razdan, R. K., Ross, R. A., & Pertwee, R. G. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707133 · Cited by 756
Malfait, A. M., Gallily, R., Sumariwalla, P. F., Malik, A. S., Andreakos, E., Mechoulam, R., & Feldmann, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.160105897 · Cited by 669
Mechoulam, R., Peters, M., Murillo‐Rodriguez, E., & Hanuš, L. O. (2007) · Chemistry & Biodiversity · doi:10.1002/cbdv.200790147 · Cited by 515 · cited 1×
“Evidence shows that CBD acts as an immunomodulator (Mechoulam et al., 2007) and exhibits a wide range of anti-inflammatory properties cense. including the inhibition of IL-6 and the activation of antiinflammatory pathways in microglial cells (Kozela et al., 2010).”
BackgroundCarrier, E. J., Auchampach, J. A., & Hillard, C. J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511232103 · Cited by 497
Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action
Zuardi, A. W. (2008) · Revista Brasileira de Psiquiatria · doi:10.1590/s1516-44462008000300015 · Cited by 421 · cited 7×
“CBD is themajor Cannabis derived non-CB1/CB2 ligand that is devoid of psychotropic effects and even, inhibits many central effects of THC (Zuardi, 2008).”
BackgroundInfluentialMaresz, K., Pryce, G., Ponomarev, E. D., Marsicano, G., Croxford, J. L., Shriver, L. P., Ledent, C., Cheng, X., Carrier, E. J., Mann, M. K., et al. (2007) · Nature Medicine · doi:10.1038/nm1561 · Cited by 363
Pertwee, R. G. (2012) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2011.0381 · Cited by 347
Therapeutic Action of Cannabinoids in a Murine Model of Multiple Sclerosis
Arévalo-Martı́n, Á., Vela, J. M., Molina-Holgado, E., Borrell, J., & Guaza, C. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-07-02511.2003 · Cited by 314
Self-citationAdhesion molecule expression and regulation on cells of the central nervous system
Lee, S. J., & Benveniste, E. N. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00084-3 · Cited by 296
Kozela, E., Pietr, M., Juknat, A., Rimmerman, N., Levy, R., & Vogel, Z. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.069294 · Cited by 286
Castillo, A., Tolón, M. R., Fernández-Ruiz, J., Romero, J., & Martinez-Orgado, J. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.10.023 · Cited by 279
B cells and antibodies in multiple sclerosis pathogenesis and therapy
Krumbholz, M., Derfuss, T., Hohlfeld, R., & Meinl, E. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.203 · Cited by 267
Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression
Rieder, S. A., Chauhan, A., Singh, U., Nagarkatti, M., & Nagarkatti, P. (2010) · Immunobiology · doi:10.1016/j.imbio.2009.04.001 · Cited by 263
Rajesh, M., Mukhopadhyay, P., Bátkai, S., Haskó, G., Liaudet, L., Huffman, J. W., Csiszar, A., Ungvari, Z., Mackie, K., Chatterjee, S., et al. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00688.2007 · Cited by 260
Cannabinoids and the immune system: An overview
Tanasescu, R., & Constantinescu, C. S. (2010) · Immunobiology · doi:10.1016/j.imbio.2009.12.005 · Cited by 239
Cannabidiol: A Promising Drug for Neurodegenerative Disorders?
Iuvone, T., Esposito, G., De Filippis, D., Scuderi, C., & Steardo, L. (2009) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2008.00065.x · Cited by 215
Chemokines and chemokine receptors in multiple sclerosis. Potential targets for new therapies
Szczuciński, A., & Losy, J. (2007) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2006.00749.x · Cited by 206
Brosnan, C. F., Cannella, B., Battistini, L., & Raine, C. S. (1995) · Neurology · doi:10.1212/wnl.45.6_suppl_6.s16 · Cited by 203
Kozela, E., Lev, N., Kaushansky, N., Eilam, R., Rimmerman, N., Levy, R., Ben‐Nun, A., Juknat, A., & Vogel, Z. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01379.x · Cited by 190
Ribeiro, A., Ferraz-de-Paula, V., Pinheiro, M. L., Vitoretti, L. B., Mariano-Souza, D. P., Quinteiro-Filho, W. M., Akamine, A. T., Almeida, V. I., Quevedo, J., Dal-Pizzol, F., et al. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.12.043 · Cited by 185
Immune cell entry into the central nervous system: Involvement of adhesion molecules and chemokines
Engelhardt, B. (2008) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.05.019 · Cited by 180
Hartung, H., Reiners, K., Archelos, J. J., MICHELS, M., Seeldrayers, P., Heidenreich, F., Pflughaupt, K. W., & Toyka, K. V. (1995) · Annals of Neurology · doi:10.1002/ana.410380210 · Cited by 174
Mechanisms of inflammation in MS tissue: adhesion molecules and chemokines
Ransohoff, R. M. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00082-x · Cited by 163
Pharmacological modulation of the endocannabinoid system in a viral model of multiple sclerosis
Mestre, L., Correa, F., Arévalo‐Martín, Á., Molina‐Holgado, E., Valenti, M., Ortar, G., Marzo, V. D., & Guaza, C. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02979.x · Cited by 144
Self-citationMecha, M., Torrao, A. S., Mestre, L., Carrillo-Salinas, F. J., Mechoulam, R., & Guaza, C. (2012) · Cell Death & Disease · doi:10.1038/cddis.2012.71 · Cited by 140
Self-citationOrtega‐Gutiérrez, S., Molina‐Holgado, E., Arévalo‐Martín, Á., Correa, F., Viso, A., López-Rodríguez, M. L., Marzo, V. D., & Guaza, C. (2005) · The FASEB Journal · doi:10.1096/fj.04-2464fje · Cited by 135
Self-citationThe role of integrins in immune-mediated diseases of the nervous system
Archelos, J. J., Previtali, S. C., & Hartung, H.-P. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01287-9 · Cited by 130
Reutershan, J., Cagnina, R. E., Chang, D., Linden, J. M., & Ley, K. F. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.2.1254 · Cited by 126
Ruiz‐Valdepeñas, L., Martínez-Orgado, J. A., Benito, C., Millán‐Uclés, Á., Tolón, R. M., & Romero, J. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-5 · Cited by 125
McPherson, J., Barringhaus, K. G., Bishop, G. G., Sanders, J. M., Rieger, J. M., Hesselbacher, S. E., Gimple, L. W., Powers, E. R., Macdonald, T. L., Sullivan, G. W., et al. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.21.5.791 · Cited by 121
Mestre, L., Docagne, F., Correa, F., Loría, F., Hernangómez, M., Borrell, J. I., & Guaza, C. (2008) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2008.10.015 · Cited by 116
Self-citationChemokine regulation of inflammation during acute viral infection
Glass, W. G., Rosenberg, H. F., & Murphy, P. M. (2003) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/00130832-200312000-00008 · Cited by 114
Docagne, F., Muñetón‐Gómez, V. C., Clemente, D., Ali, C., Loría, F., Correa, F., Hernangómez, M., Mestre, L., Vivien, D., & Guaza, C. (2007) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2006.12.005 · Cited by 109
Self-citationMecha, M., Carrillo-Salinas, F. J., Mestre, L., Feliú, A., & Guaza, C. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.11.003 · Cited by 105
Self-citationRieckmann, P., Altenhofen, B., Riegel, A., Baudewig, J., & Felgenhauer, K. (1997) · Annals of Neurology · doi:10.1002/ana.410410307 · Cited by 102
Longitudinal study of soluble adhesion molecules in multiple sclerosis
Giovannoni, G., Lai, M., Thorpe, J. E., et al. (1997) · Neurology · doi:10.1212/wnl.48.6.1557 · Cited by 92
Mechanisms of inflammation induced tissue injury in multiple sclerosis
Lassmann, H. (2008) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.04.003 · Cited by 86
Yao, S., Li, Z.-Z., Huang, Q., Li, F., Wang, Z., Augusto, E., He, J., Wang, X., Chen, J., & Zheng, R. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07807.x · Cited by 77
The discovery of natalizumab, a potent therapeutic for multiple sclerosis
Steinman, L. (2012) · The Journal of Cell Biology · doi:10.1083/jcb.201207175 · Cited by 76
Central nervous system chemokine expression during Theiler's virus-induced demyelinating disease
Hoffman, L. M., Fife, B. T., Begolka, W. S., Miller, S. D., & Karpus, W. J. (1999) · Journal of NeuroVirology · doi:10.3109/13550289909021292 · Cited by 74
Mestre, L., Iñigo, P. M., Mecha, M., Correa, F., Hernangómez, M., Loría, F., Docagne, F., Borrell, J. I., & Guaza, C. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-102 · Cited by 71
Self-citationPope, J. G., Karpus, W. J., Vanderlugt, C. J., & Miller, S. D. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.10.4050 · Cited by 68
Mecha, M. (2011) · Protocol Exchange · doi:10.1038/protex.2011.218 · Cited by 67
Self-citationUre, D., & Rodriguez, M. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00012-x · Cited by 56
CGS 21680, an agonist of the adenosine (A2A) receptor, decreases acute lung inflammation
Impellizzeri, D., Paola, R. D., Esposito, E., Mazzon, E., Paterniti, I., Melani, A., Bramanti, P., Pedata, F., & Cuzzocrea, S. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.06.049 · Cited by 54
Temporal variations of adhesion molecules and matrix metalloproteinases in the course of MS
Correale, J. D., & Molinas, M. D. L. M. B. (2003) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(03)00204-2 · Cited by 52
Croxford, J. L., Olson, J. K., Anger, H. A., & Miller, S. D. (2005) · Journal of Virology · doi:10.1128/jvi.79.13.8581-8590.2005 · Cited by 50
The Role of Cannabinoid System on Immune Modulation: Therapeutic Implications on CNS Inflammation
Correa, F., Mestre, L., Molina‐Holgado, E., Arévalo‐Martín, Á., Docagne, F., Romero, E., Molina‐Holgado, F., Borrell, J. I., & Guaza, C. (2005) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557054368790 · Cited by 40
Self-citationSativex for the management of multiple sclerosis symptoms.
Perras, C. (2005) · PubMed · Cited by 38
Cannabidiol‐induced apoptosis in murine microglial cells through lipid raft
Wu, H., Goble, K., Mecha, M., Wang, C., Huang, C., Guaza, C., & Jan, T. (2012) · Glia · doi:10.1002/glia.22345 · Cited by 27
Self-citationAnti-CCL2 treatment inhibits Theiler’s murine encephalomyelitis virus-induced demyelinating disease
Karpus, W. J., Kennedy, K. J., Fife, B. T., Bennett, J. L., Canto, M. C. D., Kunkel, S. L., & Lukacs, N. W. (2006) · Journal of NeuroVirology · doi:10.1080/13550280600873819 · Cited by 23
Lledó, A., Borrell, J. I., & Guaza, C. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00187-9 · Cited by 21
Self-citation
Cited by
Cannabinoids and the expanded endocannabinoid system in neurological disorders
Cristino, L., Bisogno, T., & Di Marzo, V. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-019-0284-z · Cited by 970
Antioxidative and Anti-Inflammatory Properties of Cannabidiol
Atalay, S., Jarocka-Karpowicz, I., & Skrzydlewska, E. (2019) · Antioxidants · doi:10.3390/antiox9010021 · Cited by 818
Alternatively activated microglia and macrophages in the central nervous system
Franco, R., & Fernández-Suárez, D. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.05.003 · Cited by 650
Cannabidiol: State of the art and new challenges for therapeutic applications
Pisanti, S., Malfitano, A. M., Ciaglia, E., Lamberti, A., Ranieri, R., Cuomo, G., Abate, M., Faggiana, G., Proto, M. C., Fiore, D., et al. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.02.041 · Cited by 614
Molecular Targets of Cannabidiol in Neurological Disorders
Ibeas Bih, C., Chen, T., Nunn, A. V. W., Bazelot, M., Dallas, M., & Whalley, B. J. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0377-3 · Cited by 578
Metadata
- Authors
- Mecha, M., Feliú, A., Iñigo, P. M., Mestre, L., Carrillo-Salinas, F. J., & Guaza, C.
- Venue
- Neurobiology of Disease
- Publisher
- Elsevier BV
- Published
- 2013-11
- Volume
- 59
- Pages
- 141-150
- ISSN
- 0969-9961 (ISSN-L)
- OpenAlex
- W1989916516
- Cited by
- 285
- References
- 59
- FWCI
- 8.04
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.